SU1405705A3 - Способ получени 7-хлор-деоксилинкомицина в виде его гидрохлорида - Google Patents
Способ получени 7-хлор-деоксилинкомицина в виде его гидрохлорида Download PDFInfo
- Publication number
- SU1405705A3 SU1405705A3 SU853984283A SU3984283A SU1405705A3 SU 1405705 A3 SU1405705 A3 SU 1405705A3 SU 853984283 A SU853984283 A SU 853984283A SU 3984283 A SU3984283 A SU 3984283A SU 1405705 A3 SU1405705 A3 SU 1405705A3
- Authority
- SU
- USSR - Soviet Union
- Prior art keywords
- mixture
- hydrochloride
- methylene chloride
- added
- chloride
- Prior art date
Links
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 title claims abstract description 32
- 238000000034 method Methods 0.000 title claims abstract description 17
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 claims abstract description 7
- 229960001595 lincomycin hydrochloride Drugs 0.000 claims abstract description 6
- POUMFISTNHIPTI-BOMBIWCESA-N hydron;(2s,4r)-n-[(1r,2r)-2-hydroxy-1-[(2r,3r,4s,5r,6r)-3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl]propyl]-1-methyl-4-propylpyrrolidine-2-carboxamide;chloride Chemical compound Cl.CN1C[C@H](CCC)C[C@H]1C(=O)N[C@H]([C@@H](C)O)[C@@H]1[C@H](O)[C@H](O)[C@@H](O)[C@@H](SC)O1 POUMFISTNHIPTI-BOMBIWCESA-N 0.000 claims abstract 3
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 claims description 14
- 239000011541 reaction mixture Substances 0.000 claims description 12
- 229910052757 nitrogen Inorganic materials 0.000 claims description 6
- OJMMVQQUTAEWLP-UHFFFAOYSA-N Lincomycin Natural products CN1CC(CCC)CC1C(=O)NC(C(C)O)C1C(O)C(O)C(O)C(SC)O1 OJMMVQQUTAEWLP-UHFFFAOYSA-N 0.000 claims description 2
- 229960005287 lincomycin Drugs 0.000 claims description 2
- OJMMVQQUTAEWLP-KIDUDLJLSA-N lincomycin Chemical compound CN1C[C@H](CCC)C[C@H]1C(=O)N[C@H]([C@@H](C)O)[C@@H]1[C@H](O)[C@H](O)[C@@H](O)[C@@H](SC)O1 OJMMVQQUTAEWLP-KIDUDLJLSA-N 0.000 claims description 2
- 125000000475 sulfinyl group Chemical group [*:2]S([*:1])=O 0.000 claims description 2
- ATHHXGZTWNVVOU-UHFFFAOYSA-N N-methylformamide Chemical compound CNC=O ATHHXGZTWNVVOU-UHFFFAOYSA-N 0.000 claims 2
- 239000003960 organic solvent Substances 0.000 claims 1
- ZMXDDKWLCZADIW-UHFFFAOYSA-N dimethylformamide Substances CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 abstract description 18
- 238000006243 chemical reaction Methods 0.000 abstract description 12
- 239000003153 chemical reaction reagent Substances 0.000 abstract description 3
- 238000010438 heat treatment Methods 0.000 abstract description 3
- 230000003115 biocidal effect Effects 0.000 abstract description 2
- 238000002360 preparation method Methods 0.000 abstract description 2
- 239000003242 anti bacterial agent Substances 0.000 abstract 1
- 230000015572 biosynthetic process Effects 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 150000002391 heterocyclic compounds Chemical class 0.000 abstract 1
- 238000003786 synthesis reaction Methods 0.000 abstract 1
- YMWUJEATGCHHMB-UHFFFAOYSA-N Dichloromethane Chemical compound ClCCl YMWUJEATGCHHMB-UHFFFAOYSA-N 0.000 description 93
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 37
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 36
- 239000000203 mixture Substances 0.000 description 33
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 24
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 16
- 239000008346 aqueous phase Substances 0.000 description 15
- 238000000605 extraction Methods 0.000 description 15
- 238000011282 treatment Methods 0.000 description 15
- 239000012453 solvate Substances 0.000 description 12
- KDLRVYVGXIQJDK-AWPVFWJPSA-N clindamycin Chemical compound CN1C[C@H](CCC)C[C@H]1C(=O)N[C@H]([C@H](C)Cl)[C@@H]1[C@H](O)[C@H](O)[C@@H](O)[C@@H](SC)O1 KDLRVYVGXIQJDK-AWPVFWJPSA-N 0.000 description 11
- 238000003756 stirring Methods 0.000 description 9
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 8
- 229960001200 clindamycin hydrochloride Drugs 0.000 description 8
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 8
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 7
- 238000001816 cooling Methods 0.000 description 7
- 239000012071 phase Substances 0.000 description 7
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 6
- 239000012074 organic phase Substances 0.000 description 6
- 239000000047 product Substances 0.000 description 6
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 5
- 238000004587 chromatography analysis Methods 0.000 description 5
- 229910052938 sodium sulfate Inorganic materials 0.000 description 5
- 235000011152 sodium sulphate Nutrition 0.000 description 5
- LFZGYTBWUHCAKF-DCNJEFSFSA-N hydron;(2s,4r)-n-[(1r,2r)-2-hydroxy-1-[(2r,3r,4s,5r,6r)-3,4,5-trihydroxy-6-methylsulfanyloxan-2-yl]propyl]-1-methyl-4-propylpyrrolidine-2-carboxamide;chloride;hydrate Chemical compound O.Cl.CN1C[C@H](CCC)C[C@H]1C(=O)N[C@H]([C@@H](C)O)[C@@H]1[C@H](O)[C@H](O)[C@@H](O)[C@@H](SC)O1 LFZGYTBWUHCAKF-DCNJEFSFSA-N 0.000 description 4
- 239000008363 phosphate buffer Substances 0.000 description 4
- 238000003109 Karl Fischer titration Methods 0.000 description 3
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 3
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical compound CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 3
- 239000000872 buffer Substances 0.000 description 3
- 229960002227 clindamycin Drugs 0.000 description 3
- 238000001035 drying Methods 0.000 description 3
- 238000001914 filtration Methods 0.000 description 3
- 239000000463 material Substances 0.000 description 3
- 239000011368 organic material Substances 0.000 description 3
- 239000000741 silica gel Substances 0.000 description 3
- 229910002027 silica gel Inorganic materials 0.000 description 3
- QGZKDVFQNNGYKY-UHFFFAOYSA-N Ammonia Chemical compound N QGZKDVFQNNGYKY-UHFFFAOYSA-N 0.000 description 2
- NEHMKBQYUWJMIP-UHFFFAOYSA-N chloromethane Chemical compound ClC NEHMKBQYUWJMIP-UHFFFAOYSA-N 0.000 description 2
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 2
- 229910000396 dipotassium phosphate Inorganic materials 0.000 description 2
- 235000019797 dipotassium phosphate Nutrition 0.000 description 2
- DZGCGKFAPXFTNM-UHFFFAOYSA-N ethanol;hydron;chloride Chemical compound Cl.CCO DZGCGKFAPXFTNM-UHFFFAOYSA-N 0.000 description 2
- 239000012458 free base Substances 0.000 description 2
- 239000007789 gas Substances 0.000 description 2
- 239000002002 slurry Substances 0.000 description 2
- 239000011343 solid material Substances 0.000 description 2
- LWIHDJKSTIGBAC-UHFFFAOYSA-K tripotassium phosphate Chemical compound [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 2
- YFHKLSPMRRWLKI-UHFFFAOYSA-N 2-tert-butyl-4-(3-tert-butyl-4-hydroxy-5-methylphenyl)sulfanyl-6-methylphenol Chemical compound CC(C)(C)C1=C(O)C(C)=CC(SC=2C=C(C(O)=C(C)C=2)C(C)(C)C)=C1 YFHKLSPMRRWLKI-UHFFFAOYSA-N 0.000 description 1
- VHUUQVKOLVNVRT-UHFFFAOYSA-N Ammonium hydroxide Chemical compound [NH4+].[OH-] VHUUQVKOLVNVRT-UHFFFAOYSA-N 0.000 description 1
- CURLTUGMZLYLDI-UHFFFAOYSA-N Carbon dioxide Chemical compound O=C=O CURLTUGMZLYLDI-UHFFFAOYSA-N 0.000 description 1
- RWSOTUBLDIXVET-UHFFFAOYSA-N Dihydrogen sulfide Chemical compound S RWSOTUBLDIXVET-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- WHXSMMKQMYFTQS-UHFFFAOYSA-N Lithium Chemical compound [Li] WHXSMMKQMYFTQS-UHFFFAOYSA-N 0.000 description 1
- 229910021529 ammonia Inorganic materials 0.000 description 1
- 239000000908 ammonium hydroxide Substances 0.000 description 1
- 235000011089 carbon dioxide Nutrition 0.000 description 1
- 239000000460 chlorine Substances 0.000 description 1
- 229910052801 chlorine Inorganic materials 0.000 description 1
- BCUPGIHTCQJCSI-UHFFFAOYSA-N chloromethanol Chemical compound OCCl BCUPGIHTCQJCSI-UHFFFAOYSA-N 0.000 description 1
- 238000001704 evaporation Methods 0.000 description 1
- 230000008020 evaporation Effects 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 239000012065 filter cake Substances 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- ZHNUHDYFZUAESO-UHFFFAOYSA-N formamide Substances NC=O ZHNUHDYFZUAESO-UHFFFAOYSA-N 0.000 description 1
- DKAGJZJALZXOOV-UHFFFAOYSA-N hydrate;hydrochloride Chemical compound O.Cl DKAGJZJALZXOOV-UHFFFAOYSA-N 0.000 description 1
- 239000007788 liquid Substances 0.000 description 1
- 229910052744 lithium Inorganic materials 0.000 description 1
- 238000011068 loading method Methods 0.000 description 1
- 229940050176 methyl chloride Drugs 0.000 description 1
- WSDQIHATCCOMLH-UHFFFAOYSA-N phenyl n-(3,5-dichlorophenyl)carbamate Chemical compound ClC1=CC(Cl)=CC(NC(=O)OC=2C=CC=CC=2)=C1 WSDQIHATCCOMLH-UHFFFAOYSA-N 0.000 description 1
- 229920005862 polyol Polymers 0.000 description 1
- 150000003077 polyols Chemical class 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 229910000160 potassium phosphate Inorganic materials 0.000 description 1
- 235000011009 potassium phosphates Nutrition 0.000 description 1
- 230000035484 reaction time Effects 0.000 description 1
- 230000000717 retained effect Effects 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- KKCBUQHMOMHUOY-UHFFFAOYSA-N sodium oxide Chemical compound [O-2].[Na+].[Na+] KKCBUQHMOMHUOY-UHFFFAOYSA-N 0.000 description 1
- 229910001948 sodium oxide Inorganic materials 0.000 description 1
- 239000007787 solid Substances 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000010421 standard material Substances 0.000 description 1
- 238000004448 titration Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07H—SUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
- C07H15/00—Compounds containing hydrocarbon or substituted hydrocarbon radicals directly attached to hetero atoms of saccharide radicals
- C07H15/02—Acyclic radicals, not substituted by cyclic structures
- C07H15/14—Acyclic radicals, not substituted by cyclic structures attached to a sulfur, selenium or tellurium atom of a saccharide radical
- C07H15/16—Lincomycin; Derivatives thereof
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Genetics & Genomics (AREA)
- Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Biotechnology (AREA)
- General Health & Medical Sciences (AREA)
- Health & Medical Sciences (AREA)
- Molecular Biology (AREA)
- Crystallography & Structural Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Peptides Or Proteins (AREA)
- Cephalosporin Compounds (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US67615784A | 1984-11-29 | 1984-11-29 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SU1405705A3 true SU1405705A3 (ru) | 1988-06-23 |
Family
ID=24713464
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SU853984283A SU1405705A3 (ru) | 1984-11-29 | 1985-11-28 | Способ получени 7-хлор-деоксилинкомицина в виде его гидрохлорида |
Country Status (19)
| Country | Link |
|---|---|
| US (1) | US4710565A (enExample) |
| EP (1) | EP0183505B1 (enExample) |
| JP (1) | JPH0649714B2 (enExample) |
| KR (1) | KR930003492B1 (enExample) |
| CN (2) | CN1004002B (enExample) |
| AT (1) | ATE50265T1 (enExample) |
| AU (1) | AU574232B2 (enExample) |
| CA (1) | CA1238319A (enExample) |
| DE (1) | DE3575930D1 (enExample) |
| DK (1) | DK165010C (enExample) |
| ES (1) | ES8605817A1 (enExample) |
| FI (1) | FI78708C (enExample) |
| GR (1) | GR852861B (enExample) |
| HU (1) | HU199497B (enExample) |
| IL (1) | IL76778A (enExample) |
| MX (1) | MX162251A (enExample) |
| PT (1) | PT81496B (enExample) |
| SU (1) | SU1405705A3 (enExample) |
| ZA (1) | ZA858117B (enExample) |
Families Citing this family (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4568741A (en) * | 1984-05-15 | 1986-02-04 | The Upjohn Company | Synthesis of 7-halo-7-deoxylincomycins |
| JP2531877Y2 (ja) * | 1988-12-15 | 1997-04-09 | 日東工器株式会社 | 電磁式ダイアフラムポンプ |
| JP2531876Y2 (ja) * | 1988-12-15 | 1997-04-09 | 日東工器株式会社 | 電磁式ダイアフラムポンプ用マグネットホルダ |
| JP2544782Y2 (ja) * | 1988-12-27 | 1997-08-20 | 日東工器株式会社 | 電磁式ダイアフラムポンプ用マグネットホルダ |
| US6565882B2 (en) | 2000-02-24 | 2003-05-20 | Advancis Pharmaceutical Corp | Antibiotic composition with inhibitor |
| US6544555B2 (en) | 2000-02-24 | 2003-04-08 | Advancis Pharmaceutical Corp. | Antibiotic product, use and formulation thereof |
| US20020068078A1 (en) | 2000-10-13 | 2002-06-06 | Rudnic Edward M. | Antifungal product, use and formulation thereof |
| US6541014B2 (en) | 2000-10-13 | 2003-04-01 | Advancis Pharmaceutical Corp. | Antiviral product, use and formulation thereof |
| ATE298758T1 (de) * | 2001-08-28 | 2005-07-15 | Pharmacia Corp | Kristalline freie base von clindamycin |
| MXPA05001689A (es) * | 2002-08-15 | 2005-05-27 | Vicuron Pharm Inc | Derivados de lincomicina que poseen actividad antibacteriana. |
| US7199105B2 (en) * | 2002-08-15 | 2007-04-03 | Vicuron Pharmaceuticals, Inc. | Lincomycin derivatives possessing antibacterial activity |
| EA009031B1 (ru) | 2003-01-24 | 2007-10-26 | Стифел Рисерч Оустрэйлиа Пти Лтд. | Пена на основе фосфата клиндамицина |
| US7199106B2 (en) | 2003-06-17 | 2007-04-03 | Vicuron Pharmaceuticals, Inc. | Lincomycin derivatives possessing antimicrobial activity |
| US7256177B2 (en) | 2003-06-17 | 2007-08-14 | Vicuron Pharmaceuticals, Inc. | Lincomycin derivatives possessing antibacterial activity |
| AU2004258949B2 (en) | 2003-07-21 | 2011-02-10 | Shionogi, Inc. | Antibiotic product, use and formulation thereof |
| JP2006528190A (ja) | 2003-07-21 | 2006-12-14 | アドバンシス ファーマスーティカル コーポレイション | 抗生物質製剤、その使用法及び作成方法 |
| JP2006528185A (ja) | 2003-07-21 | 2006-12-14 | アドバンシス ファーマスーティカル コーポレイション | 抗生物質製剤、その使用法及び作成方法 |
| EP1653925A1 (en) | 2003-08-11 | 2006-05-10 | Advancis Pharmaceutical Corporation | Robust pellet |
| WO2005016278A2 (en) | 2003-08-12 | 2005-02-24 | Advancis Pharmaceuticals Corporation | Antibiotic product, use and formulation thereof |
| WO2005023184A2 (en) | 2003-08-29 | 2005-03-17 | Advancis Pharmaceuticals Corporation | Antibiotic product, use and formulation thereof |
| US8460710B2 (en) | 2003-09-15 | 2013-06-11 | Shionogi, Inc. | Antibiotic product, use and formulation thereof |
| US7361743B2 (en) * | 2004-02-11 | 2008-04-22 | Pfizer Inc | Lincomycin derivatives possessing antibacterial activity |
| AU2005269981A1 (en) | 2004-07-02 | 2006-02-09 | Bonck, John A | Tablet for pulsed delivery |
| US8778924B2 (en) | 2006-12-04 | 2014-07-15 | Shionogi Inc. | Modified release amoxicillin products |
| US8357394B2 (en) | 2005-12-08 | 2013-01-22 | Shionogi Inc. | Compositions and methods for improved efficacy of penicillin-type antibiotics |
| WO2007099557A2 (en) * | 2006-02-28 | 2007-09-07 | V. B. Medicare Pvt. Ltd. | Process for the production of a chlorinating reagent and its use in the preparation of chlorinated sugars |
| PL2206494T3 (pl) | 2006-03-31 | 2016-06-30 | Stiefel Res Australia Pty Ltd | Spienialny żel zawiesinowy |
| US8299052B2 (en) | 2006-05-05 | 2012-10-30 | Shionogi Inc. | Pharmaceutical compositions and methods for improved bacterial eradication |
| CN101205245B (zh) * | 2007-12-06 | 2011-04-06 | 河南天方药业股份有限公司 | 盐酸克林霉素的制备方法 |
| CN102675146A (zh) * | 2012-05-22 | 2012-09-19 | 山东凯盛新材料股份有限公司 | 新型固体氯化剂（氯亚甲基）二甲基氯化铵的制备方法 |
Family Cites Families (5)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3496163A (en) * | 1965-02-08 | 1970-02-17 | Upjohn Co | 7-halo-7-deoxylincomycins and process for preparing the same |
| US3435025A (en) * | 1966-03-18 | 1969-03-25 | Upjohn Co | 7-deoxylincomycin and analogs and isomers thereof and process for making the same |
| US3580904A (en) * | 1969-04-03 | 1971-05-25 | Upjohn Co | 7-halo-7-deoxy-lincomycin derivatives |
| US3574186A (en) * | 1969-10-08 | 1971-04-06 | Upjohn Co | Process for making 7-chloro-7-deoxylincomycin and related compounds and novel intermediates produced therein |
| US4568741A (en) * | 1984-05-15 | 1986-02-04 | The Upjohn Company | Synthesis of 7-halo-7-deoxylincomycins |
-
1985
- 1985-04-01 CN CN85101921.8A patent/CN1004002B/zh not_active Expired
- 1985-10-11 CA CA000492862A patent/CA1238319A/en not_active Expired
- 1985-10-18 AU AU48837/85A patent/AU574232B2/en not_active Expired
- 1985-10-22 ZA ZA858117A patent/ZA858117B/xx unknown
- 1985-10-22 IL IL76778A patent/IL76778A/xx not_active IP Right Cessation
- 1985-10-23 ES ES548152A patent/ES8605817A1/es not_active Expired
- 1985-11-14 CN CN85108244A patent/CN1016694B/zh not_active Expired
- 1985-11-14 PT PT81496A patent/PT81496B/pt unknown
- 1985-11-19 MX MX661A patent/MX162251A/es unknown
- 1985-11-22 DK DK542785A patent/DK165010C/da not_active IP Right Cessation
- 1985-11-25 AT AT85308539T patent/ATE50265T1/de not_active IP Right Cessation
- 1985-11-25 DE DE8585308539T patent/DE3575930D1/de not_active Expired - Lifetime
- 1985-11-25 EP EP85308539A patent/EP0183505B1/en not_active Expired - Lifetime
- 1985-11-27 GR GR852861A patent/GR852861B/el unknown
- 1985-11-28 JP JP60269229A patent/JPH0649714B2/ja not_active Expired - Lifetime
- 1985-11-28 FI FI854711A patent/FI78708C/fi not_active IP Right Cessation
- 1985-11-28 SU SU853984283A patent/SU1405705A3/ru active
- 1985-11-28 KR KR1019850008893A patent/KR930003492B1/ko not_active Expired - Lifetime
- 1985-11-29 HU HU854580A patent/HU199497B/hu unknown
-
1986
- 1986-01-24 US US06/822,044 patent/US4710565A/en not_active Expired - Lifetime
Non-Patent Citations (1)
| Title |
|---|
| Патент US 3155580, кл. 260-210, 1966. Патент US 3574186, кл. 260-210, 1971. * |
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| SU1405705A3 (ru) | Способ получени 7-хлор-деоксилинкомицина в виде его гидрохлорида | |
| RU2066324C1 (ru) | Кристаллический дигидрат азитромицина и способ его получения | |
| SU578887A3 (ru) | Способ получени фталидного эфира 6-( )-( -аминофенилацетамидо)-пенициллановой кислоты или его аддитивных солей | |
| SU613724A3 (ru) | Способ получени 8-тиометил-эрголинов или их солей | |
| CS197271B1 (en) | Process for preparing derivatives of rifamycine | |
| SU628822A3 (ru) | Способ получени хлоргидрата 4 -эпи-6 оксиадриамицина | |
| SU837326A3 (ru) | Способ получени 4"-дезокси-4"-OKCO-эРиТРОМициНА A | |
| SU625612A3 (ru) | Способ получени эрголиновых соединений или их солей | |
| SU884572A3 (ru) | Способ получени производных лизергола | |
| SU578865A3 (ru) | Способ получени гидрохлорида -6-дезокси-5-окситетрациклина | |
| SU558644A3 (ru) | Способ получени имидазолов или их солей | |
| US4865765A (en) | Ursodeoxycholic acid derivatives and their inorganic and organic salts having therapeutic activity, and process for preparing the same | |
| EP0137132A2 (en) | Process for the manufacture of 7,16-dioxa-2-aza-10-0-cladinosyl-12-0-desosaminyl-4,5-dihydroxy-6-ethyl-3,5,9,11,13,15-hexamethyl-bicyclo(11.2.1)-hexadeca-1(2)-ene-8-one and novel intermediate used in this process | |
| US4359416A (en) | Process for preparing L-carnosine | |
| SU1657063A3 (ru) | Способ получени этиленсульфата | |
| SU543355A3 (ru) | Способ получени производных глюкозы | |
| SU604497A3 (ru) | Способ получени тетрамизола или его солей | |
| JP2578797B2 (ja) | Ｎ−（スルホニルメチル）ホルムアミド類の製造法 | |
| SU1080744A3 (ru) | Способ получени производных бензодиазепина | |
| SU1114677A1 (ru) | Способ получени бензо-2,1,3-тиадиазола | |
| SU593660A3 (ru) | Способ получени производных замещенной -аминооксигидроксамоновой кислоты | |
| US4070363A (en) | Manufacture of tetramisole | |
| WO2001016115A1 (en) | Process for synthesizing isoxazolidines | |
| SU1114336A3 (ru) | Способ получени сложных эфиров аповинкаминовой кислоты | |
| EP0018732B1 (en) | An alpha-methyl-4(2'-thienyl-carbonyl)phenyl acetic acid derivative, process for its preparation and its pharmaceutical use |